Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51-24-1

Post Buying Request

51-24-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51-24-1 Usage

Chemical Properties

White to Off-White Solid

Originator

Triacana,Ana,Italy,1972

Uses

Different sources of media describe the Uses of 51-24-1 differently. You can refer to the following data:
1. 3,3'',5-Triiodo Thyroacetic Acid (T3-Acetic Acid (USP)) is a thyroid hormone analogue. A potent Thyroxine impurity. Levothyroxine EP Impurity C.
2. Thyroid hormone analogue
3. thyroid agent

Manufacturing Process

Preparation of 3:5-diiodo-4-(4'-hydroxyphenoxy)phenylacetic acid (diacid): A solution of ethyl 3:5-diiodo-4-(4'-methoxyphenoxy)phenyl acetate (9.5 g) in acetic acid (60 ml) was heated under reflux with hydroiodic acid (SG 1.7, 50 ml) and red phosphorus (0.5 g) for 1 hour. The hot solution was filtered and the filtrate concentrated at 50°C and 15 mm of mercury to above 20 ml. The residue was treated with water (70 ml) containing a little sodium thiosulfate to decolorize the product. The solid was collected by filtration and purified by the method of Harington and Pitt-Rivers [Biochem. J. (1952), Vol. 50, page 438]. Yield 8.36 g (95%). After crystallization from 70% (v/v) acetic acid it melted at 219°C. A solution of 438 mg of diac in methanol (20 ml) and ammonia solution (SG 0.88; 20 ml) was iodinated at 0°C with 1.8 ml 1 N iodine solution. The product was isolated in almost theoretical yield in a manner similar to that described for tetrac. After crystallization from 50% (v/v) methanol, triac was obtained as colorless needles which melted over the range 65°C to 90°C according to the rate of heating. The molten form resolidified at about 110°C and finally melted at 180°C to 181°C without decomposition. The compound, dried at 25°C/3 mm over silica gel, contains methanol of crystallization.

Therapeutic Function

Thyroid hormone

Check Digit Verification of cas no

The CAS Registry Mumber 51-24-1 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51-24:
(4*5)+(3*1)+(2*2)+(1*4)=31
31 % 10 = 1
So 51-24-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)

51-24-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid

1.2 Other means of identification

Product number -
Other names Triac

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51-24-1 SDS

51-24-1Synthetic route

2-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)acetic acid
1155-40-4

2-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)acetic acid

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

Conditions
ConditionsYield
With ammonia anschliessendes Behandeln mit wss. Jod-KI-Loesung;
3,3',5-triiodothyroacetic acid ethyl ester
41628-06-2

3,3',5-triiodothyroacetic acid ethyl ester

A

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

B

[4-(4-Hydroxy-3-iodo-phenoxy)-3-iodo-5-trifluoromethyl-phenyl]-acetic acid

[4-(4-Hydroxy-3-iodo-phenoxy)-3-iodo-5-trifluoromethyl-phenyl]-acetic acid

C

[4-(4-Hydroxy-3-trifluoromethyl-phenoxy)-3,5-diiodo-phenyl]-acetic acid

[4-(4-Hydroxy-3-trifluoromethyl-phenoxy)-3,5-diiodo-phenyl]-acetic acid

D

[4-(4-Hydroxy-3-trifluoromethyl-phenoxy)-3-iodo-5-trifluoromethyl-phenyl]-acetic acid

[4-(4-Hydroxy-3-trifluoromethyl-phenoxy)-3-iodo-5-trifluoromethyl-phenyl]-acetic acid

Conditions
ConditionsYield
With N,N,N,N,N,N-hexamethylphosphoric triamide; sodium hydroxide; dibromodifluoromethane; copper(I) bromide; cadmium Multistep reaction. Further byproducts given. Title compound not separated from byproducts;
[3,5-diiodo-4-(4-methoxy-phenoxy)-phenyl]-acetic acid ethyl ester
85828-82-6

[3,5-diiodo-4-(4-methoxy-phenoxy)-phenyl]-acetic acid ethyl ester

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aqueous HI; red phosphorus; acetic acid
2: aqueous methanol. NH3 / anschliessendes Behandeln mit wss. Jod-KI-Loesung
View Scheme
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

methylamine
74-89-5

methylamine

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-methylacetamide
1417653-47-4

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-methylacetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With 1,1'-carbonyldiimidazole In tetrahydrofuran at 50℃; for 2h; Sealed tube; Inert atmosphere;
Stage #2: methylamine In tetrahydrofuran at 20 - 50℃; for 16h; Inert atmosphere;
87%
Stage #1: 3,3',5-triiodothyroacetic acid With 1,1'-carbonyldiimidazole In tetrahydrofuran at 50℃; for 2h; Inert atmosphere; Sealed tube;
Stage #2: methylamine In tetrahydrofuran at 20 - 50℃; for 16h; Inert atmosphere;
87%
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: methylamine In N,N-dimethyl-formamide
40%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

dimethyl amine
124-40-3

dimethyl amine

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N,N-dimethylacetamide
1417653-48-5

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N,N-dimethylacetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: dimethyl amine In N,N-dimethyl-formamide
60%
morpholine
110-91-8

morpholine

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-1-morpholinoethanone
1417653-54-3

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-1-morpholinoethanone

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: morpholine In N,N-dimethyl-formamide
43%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetamide
92905-78-7

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With thionyl chloride for 2h; Reflux;
Stage #2: With ammonium hydroxide In water; toluene for 0.0833333h;
40%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

1-pentanamine
110-58-7

1-pentanamine

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-pentylacetamide
1417653-46-3

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-pentylacetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: n-Pentylamine In N,N-dimethyl-formamide
36%
piperidine
110-89-4

piperidine

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-1-(piperidin-1-yl)ethanone
1417653-45-2

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-1-(piperidin-1-yl)ethanone

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: piperidine In N,N-dimethyl-formamide
31%
methanesulfonamide
3144-09-0

methanesulfonamide

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-(methylsulfonyl)acetamide
1417653-49-6

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-(methylsulfonyl)acetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With 1,1'-carbonyldiimidazole In dichloromethane at 0 - 20℃; for 1h;
Stage #2: methanesulfonamide With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane
21%
benzenesulfonamide
98-10-2

benzenesulfonamide

3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-(phenylsulfonyl)acetamide
1417653-50-9

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-(phenylsulfonyl)acetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With 1,1'-carbonyldiimidazole In dichloromethane at 0 - 20℃;
Stage #2: benzenesulfonamide With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane
16%
Stage #1: 3,3',5-triiodothyroacetic acid With 1,1'-carbonyldiimidazole In dichloromethane at 0 - 20℃; for 1h;
Stage #2: benzenesulfonamide With 1,8-diazabicyclo[5.4.0]undec-7-ene In dichloromethane
16%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

aniline
62-53-3

aniline

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-phenylacetamide
1417653-39-4

2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-N-phenylacetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: aniline In N,N-dimethyl-formamide
16%
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: aniline In N,N-dimethyl-formamide
16%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

diethylamine
109-89-7

diethylamine

N,N-diethyl-2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetamide
1417653-43-0

N,N-diethyl-2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetamide

Conditions
ConditionsYield
Stage #1: 3,3',5-triiodothyroacetic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide for 0.5h;
Stage #2: diethylamine In N,N-dimethyl-formamide
8%
3,3',5-triiodothyroacetic acid
51-24-1

3,3',5-triiodothyroacetic acid

4-(4-Hydroxy-3-iod-phenoxy)-3,5-diiod-phenethylalkohol
736-05-0

4-(4-Hydroxy-3-iod-phenoxy)-3,5-diiod-phenethylalkohol

Conditions
ConditionsYield
With diborane In tetrahydrofuran

51-24-1Relevant articles and documents

Deiodotrifluoromethylation of ethyl 3,3',5-triiodothyroacetate. Divergent derivatization based on the combinatorial concept

Sagi, Kazuyuki,Kagechika, Hiroyuki,Fukasawa, Hiroshi,Hashimoto, Yuichi,Shudo, Koichi

, p. 1273 - 1275 (1996)

A strategy for development of thyroid hormone analogs was examined based on the combinatorial concept. The reaction of ethyl 3,3',5- triiodothyroacetate (3b) with Cd/Br2CF2/CuBr followed by ester hydrolysis gave a mixture of more than ten products as detected by HPLC. The structures of the products in the bioactive fractions showed that the replacement of iodides with trifluoromethyl groups is an effective approach for obtaining thyromimetics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51-24-1